Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Journal of Cancer Research and Therapeutics|April 6, 2022
Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcomeMarina K Ibragimova, Matvey M Tsyganov, Irina V Deryusheva, et al.Current Cancer Drug Targets|October 3, 2019
Neoadjuvant Chemotherapy Induces the Appearance of New Copy Number Aberrations in Breast Tumor and is Associated with MetastasisNikolai V Litviakov, Marina K Ibragimova, Matvey M Tsyganov, et al.Journal of Korean Medical Science|December 21, 2019
Amplification of Stem Genes: New Potential Metastatic Makers in Patients with an Early Form of Breast CancerMatvey M Tsyganov, Marina K Ibragimova, Alina M Pevzner, et al.Microorganisms|January 21, 2023
Human Papillomavirus in Non-Small Cell Lung Carcinoma: Assessing Virus Presence in Tumor and Normal Tissues and Its Clinical RelevanceMatvey M Tsyganov, Marina K Ibragimova, Evgeniy O Rodionov, et al.Oncotarget|January 23, 2016
Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapyNikolai V Litviakov, Nadezhda V Cherdyntseva, Matvey M Tsyganov, et al.Cancer Chemotherapy and Pharmacology|June 12, 2017
Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancerMatvey M Tsyganov, Maxim B Freidin, Marina K Ibragimova, et al.Journal of Personalized Medicine|October 27, 2022
Personalized Prescription of Chemotherapy Based on Assessment of mRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-Small-Cell Lung CancerMatvey M Tsyganov, Evgeny O Rodionov, Marina K Ibragimova, et al.Journal of Personalized Medicine|June 2, 2021
Amplifications of Stemness Gene Loci-New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective StudyNikolai V Litviakov, Marina K Ibragimova, Matvey M Tsyganov, et al.Pharmaceutics|May 28, 2022
DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the DiseaseMatvey M Tsyganov, Marina K Ibragimova, Kseniya A Gaptulbarova, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Prognostic significance of ERCC1, RRM1, TOP1, TOP2A, TYMS, TUBB3, GSTP1 AND BRCA1 mRNA expressions in patients with non-small-cell lung cancer receiving a platinum-based chemotherapyMatvey M Tsyganov, Evgeny O Rodionov, Alina M Pevzner, et al.Pageof 3